ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/11/12 | 3,095 | 3,160 | 3,080 | 3,100 | +65 | +2.1% | 920,200 |
2024/11/11 | 3,005 | 3,045 | 2,974 | 3,035 | +25 | +0.8% | 547,800 |
2024/11/08 | 2,961 | 3,035 | 2,936 | 3,010 | +79 | +2.7% | 777,700 |
2024/11/07 | 3,055 | 3,070 | 2,913 | 2,931 | -89 | -2.9% | 1,060,300 |
2024/11/06 | 2,984 | 3,065 | 2,975 | 3,020 | +43 | +1.4% | 774,900 |
2024/11/05 | 3,030 | 3,060 | 2,976 | 2,977 | -48 | -1.6% | 552,400 |
2024/11/01 | 3,020 | 3,040 | 2,961 | 3,025 | -65 | -2.1% | 728,700 |
2024/10/31 | 3,040 | 3,095 | 3,010 | 3,090 | +40 | +1.3% | 441,000 |
2024/10/30 | 3,020 | 3,135 | 2,993 | 3,050 | +30 | +1% | 867,300 |
2024/10/29 | 2,962 | 3,030 | 2,945 | 3,020 | +58 | +2% | 812,400 |
2024/10/28 | 2,802 | 2,962 | 2,800 | 2,962 | +163 | +5.8% | 1,074,800 |
2024/10/25 | 2,755 | 2,819 | 2,731 | 2,799 | ±0 | ±0% | 999,400 |
2024/10/24 | 2,861 | 2,875 | 2,751 | 2,799 | -101 | -3.5% | 1,445,600 |
2024/10/23 | 3,005 | 3,060 | 2,875 | 2,900 | -80 | -2.7% | 1,343,000 |
2024/10/22 | 3,005 | 3,005 | 2,918 | 2,980 | -70 | -2.3% | 1,099,900 |
2024/10/21 | 2,918 | 3,065 | 2,910 | 3,050 | +108 | +3.7% | 830,500 |
2024/10/18 | 2,952 | 2,982 | 2,902 | 2,942 | -28 | -0.9% | 622,100 |
2024/10/17 | 2,977 | 3,045 | 2,941 | 2,970 | -4 | -0.1% | 985,000 |
2024/10/16 | 2,860 | 2,986 | 2,835 | 2,974 | +87 | +3% | 780,200 |
2024/10/15 | 2,897 | 2,925 | 2,825 | 2,887 | +30 | +1.1% | 824,600 |
2024/10/11 | 2,840 | 2,878 | 2,818 | 2,857 | +4 | +0.1% | 623,700 |
2024/10/10 | 2,918 | 2,928 | 2,842 | 2,853 | -83 | -2.8% | 1,025,400 |
2024/10/09 | 2,966 | 3,095 | 2,925 | 2,936 | +20 | +0.7% | 1,665,600 |
2024/10/08 | 2,951 | 2,999 | 2,871 | 2,916 | -46 | -1.6% | 1,040,100 |
2024/10/07 | 2,900 | 2,978 | 2,856 | 2,962 | +112 | +3.9% | 1,176,800 |
2024/10/04 | 2,891 | 2,913 | 2,802 | 2,850 | -64 | -2.2% | 1,248,200 |
2024/10/03 | 2,954 | 2,968 | 2,832 | 2,914 | +39 | +1.4% | 1,606,700 |
2024/10/02 | 2,965 | 3,010 | 2,857 | 2,875 | -160 | -5.3% | 1,688,400 |
2024/10/01 | 2,915 | 3,120 | 2,836 | 3,035 | +148 | +5.1% | 1,991,700 |
2024/09/30 | 2,927 | 2,952 | 2,880 | 2,887 | -90 | -3% | 1,838,400 |
2024/09/27 | 2,860 | 3,005 | 2,851 | 2,977 | +116 | +4.1% | 1,943,200 |
2024/09/26 | 2,785 | 2,872 | 2,742 | 2,861 | +83 | +3% | 1,464,900 |
2024/09/25 | 2,701 | 2,793 | 2,698 | 2,778 | +55 | +2% | 1,152,300 |
2024/09/24 | 2,754 | 2,796 | 2,706 | 2,723 | -13 | -0.5% | 1,641,200 |
2024/09/20 | 2,682 | 2,760 | 2,640 | 2,736 | +98 | +3.7% | 2,104,100 |
2024/09/19 | 2,531 | 2,665 | 2,497 | 2,638 | +145 | +5.8% | 2,385,700 |
2024/09/18 | 2,475 | 2,497 | 2,375 | 2,493 | +58 | +2.4% | 1,328,900 |
2024/09/17 | 2,499 | 2,531 | 2,349 | 2,435 | -60 | -2.4% | 1,778,800 |
2024/09/13 | 2,455 | 2,571 | 2,405 | 2,495 | +232 | +10.3% | 4,486,100 |
2024/09/12 | 2,218 | 2,284 | 2,193 | 2,263 | +120 | +5.6% | 1,366,500 |
2024/09/11 | 2,228 | 2,237 | 2,111 | 2,143 | -84 | -3.8% | 1,129,900 |
2024/09/10 | 2,149 | 2,260 | 2,114 | 2,227 | +111 | +5.2% | 926,100 |
2024/09/09 | 2,016 | 2,151 | 2,001 | 2,116 | +21 | +1% | 1,147,900 |
2024/09/06 | 2,140 | 2,148 | 2,078 | 2,095 | -47 | -2.2% | 861,100 |
2024/09/05 | 2,058 | 2,160 | 2,058 | 2,142 | +60 | +2.9% | 1,191,400 |
2024/09/04 | 2,097 | 2,141 | 2,042 | 2,082 | -148 | -6.6% | 1,772,800 |
2024/09/03 | 2,245 | 2,299 | 2,171 | 2,230 | -17 | -0.8% | 1,422,800 |
2024/09/02 | 2,320 | 2,333 | 2,238 | 2,247 | -42 | -1.8% | 1,369,400 |
2024/08/30 | 2,331 | 2,358 | 2,239 | 2,289 | -46 | -2% | 1,989,100 |
2024/08/29 | 2,250 | 2,449 | 2,184 | 2,335 | +95 | +4.2% | 4,058,600 |
101~
150
件表示中 / 3678件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 180,700円 | +21.7% | +999.9% | 0.00% | 7.52倍 | 2.49倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 293,400円 | +3.0% | +27.5% | 2.73% | 18.57倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 141,700円 | +3.2% | +4.5% | 3.67% | 16.28倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 208,800円 | +0.4% | -8.4% | 2.54% | 26.81倍 | 1.52倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
クオリプス | 890,000円 | +660.9% | - | 0.00% | - | 12.92倍 |
|
大阪大学発ベンチャー。iPS細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
市場注目の銘柄
チャート関連のコラム